{"id":516395,"date":"2021-07-22T08:06:06","date_gmt":"2021-07-22T12:06:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/"},"modified":"2021-07-22T08:06:06","modified_gmt":"2021-07-22T12:06:06","slug":"volpara-collaborates-with-invitae-corporation-leading-genetics-company","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/","title":{"rendered":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company"},"content":{"rendered":"
\n

Collaboration Expands Access to Genetic Testing and Risk Assessment Capabilities Available through Volpara’s Breast Health Platform<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SEATTLE<\/span>, July 22, 2021<\/span> \/PRNewswire\/ —\u00a0Volpara Health,\u00a0a\u00a0global health technology software leader providing an integrated breast care platform for the delivery of personalized\u00a0breast care,\u00a0has\u00a0signed an\u00a0agreement\u00a0with\u00a0Invitae\u00a0Corporation, a leader in medical genetics,\u00a0to bring\u00a0Invitae’s\u00a0genetic testing services to\u00a0Volpara’s\u00a0customers\u00a0in the United States.\u00a0<\/p>\n

\n

\n
\n \"\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Volpara’s\u00a0United States\u00a0customers will gain access to\u00a0Invitae’s\u00a0comprehensive\u00a0genetic testing\u00a0services\u00a0within\u00a0Volpara’s\u00a0software workflow. Volpara\u00a0plans to create an\u00a0integrated\u00a0ordering process for\u00a0Invitae\u00a0genetic testing\u00a0services\u00a0within\u00a0its suite of\u00a0products to provide women with additional access to comprehensive genetic testing services through a variety of clinical settings.\u00a0 <\/p>\n

Customers can utilize\u00a0Volpara’s\u00a0market-leading\u00a0breast cancer risk assessment software\u00a0to\u00a0confidently make informed decisions\u00a0for\u00a0triaging patients to supplemental imaging and\/or genetic testing based on\u00a0their\u00a0personalized\u00a0risk.\u00a0Risk assessment is also required by insurance companies\u00a0in the United States\u00a0to justify reimbursement for additional testing.\u00a0Along with\u00a0supplemental screening, such as ultrasound and MRI,\u00a0genetic testing assists\u00a0in earlier cancer detection\u00a0and\u00a0is critical in reducing treatment costs and increasing the chances of survival.\u00a0<\/p>\n

“Volpara\u00a0continues to be\u00a0proud\u00a0of its\u00a0major role in\u00a0improving access to genetic testing and risk assessment critical to drive adoption of\u00a0personalized breast screening\u00a0in the United States<\/span>. Our\u00a0relationship\u00a0with\u00a0Invitae\u00a0adds\u00a0a\u00a0prominent lab\u00a0to the genetic services available through our breast health platform and\u00a0will allow us to offer\u00a0increased\u00a0value to customers\u00a0by\u00a0ensuring that\u00a0the right patients get\u00a0seamless\u00a0access to the\u00a0right\u00a0genetic\u00a0testing at the right time,”\u00a0said Dr. Ralph\u00a0Highnam, Group CEO of\u00a0Volpara.<\/p>\n

“While the value of genetic information in cancer care is well established, the ability to combine genetics with breast density and other forms of risk assessment to guide patient care remains underutilized,” said Robert Nussbaum<\/span>, M.D., chief medical officer of Invitae. “In working with Volpara, we want to make it easier for clinicians and oncologists to access genetic testing services to ensure that their patients have comprehensive and personalized medical information to better inform their healthcare decisions.<\/p>\n

\n About Invitae
<\/b>Invitae Corporation\u00a0(NYSE: NVTA)\u00a0is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company’s website at\u00a0invitae.com<\/a><\/u>.<\/p>\n

\n About Volpara
<\/b>Volpara provides an advanced AI software platform that works with a healthcare provider’s expertise to enable a high-quality, optimized, and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient’s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. These capabilities are being extended to lung cancer screening. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations including FDA clearance and CE marking, and is validated by a volume of peer-reviewed publications unrivaled in the breast screening industry. For more information, visit https:\/\/www.volparahealth.com<\/a><\/u>.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/volpara-collaborates-with-invitae-corporation-leading-genetics-company-301339165.html<\/a><\/p>\n

SOURCE Volpara Health<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Collaboration Expands Access to Genetic Testing and Risk Assessment Capabilities Available through Volpara’s Breast Health Platform PR Newswire SEATTLE, July 22, 2021 \/PRNewswire\/ —\u00a0Volpara Health,\u00a0a\u00a0global health technology software leader providing an integrated breast care platform for the delivery of personalized\u00a0breast care,\u00a0has\u00a0signed an\u00a0agreement\u00a0with\u00a0Invitae\u00a0Corporation, a leader in medical genetics,\u00a0to bring\u00a0Invitae’s\u00a0genetic testing services to\u00a0Volpara’s\u00a0customers\u00a0in the United States.\u00a0 Volpara’s\u00a0United States\u00a0customers will gain access to\u00a0Invitae’s\u00a0comprehensive\u00a0genetic testing\u00a0services\u00a0within\u00a0Volpara’s\u00a0software workflow. Volpara\u00a0plans to create an\u00a0integrated\u00a0ordering process for\u00a0Invitae\u00a0genetic testing\u00a0services\u00a0within\u00a0its suite of\u00a0products to provide women with additional access to comprehensive genetic testing services through a variety of clinical settings.\u00a0 Customers can utilize\u00a0Volpara’s\u00a0market-leading\u00a0breast cancer risk assessment software\u00a0to\u00a0confidently make informed decisions\u00a0for\u00a0triaging patients to supplemental imaging and\/or genetic testing based on\u00a0their\u00a0personalized\u00a0risk.\u00a0Risk assessment is also required by insurance companies\u00a0in the United States\u00a0to justify reimbursement for … <\/p>\n

Continue reading “Volpara Collaborates With Invitae Corporation, Leading Genetics Company”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVolpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Collaboration Expands Access to Genetic Testing and Risk Assessment Capabilities Available through Volpara’s Breast Health Platform PR Newswire SEATTLE, July 22, 2021 \/PRNewswire\/ —\u00a0Volpara Health,\u00a0a\u00a0global health technology software leader providing an integrated breast care platform for the delivery of personalized\u00a0breast care,\u00a0has\u00a0signed an\u00a0agreement\u00a0with\u00a0Invitae\u00a0Corporation, a leader in medical genetics,\u00a0to bring\u00a0Invitae’s\u00a0genetic testing services to\u00a0Volpara’s\u00a0customers\u00a0in the United States.\u00a0 Volpara’s\u00a0United States\u00a0customers will gain access to\u00a0Invitae’s\u00a0comprehensive\u00a0genetic testing\u00a0services\u00a0within\u00a0Volpara’s\u00a0software workflow. Volpara\u00a0plans to create an\u00a0integrated\u00a0ordering process for\u00a0Invitae\u00a0genetic testing\u00a0services\u00a0within\u00a0its suite of\u00a0products to provide women with additional access to comprehensive genetic testing services through a variety of clinical settings.\u00a0 Customers can utilize\u00a0Volpara’s\u00a0market-leading\u00a0breast cancer risk assessment software\u00a0to\u00a0confidently make informed decisions\u00a0for\u00a0triaging patients to supplemental imaging and\/or genetic testing based on\u00a0their\u00a0personalized\u00a0risk.\u00a0Risk assessment is also required by insurance companies\u00a0in the United States\u00a0to justify reimbursement for … Continue reading "Volpara Collaborates With Invitae Corporation, Leading Genetics Company"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T12:06:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Volpara Collaborates With Invitae Corporation, Leading Genetics Company\",\"datePublished\":\"2021-07-22T12:06:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/\"},\"wordCount\":564,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/389465\\\/Volpara_Solutions_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/\",\"name\":\"Volpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/389465\\\/Volpara_Solutions_Logo.jpg\",\"datePublished\":\"2021-07-22T12:06:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/389465\\\/Volpara_Solutions_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/389465\\\/Volpara_Solutions_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volpara Collaborates With Invitae Corporation, Leading Genetics Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/","og_locale":"en_US","og_type":"article","og_title":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk","og_description":"Collaboration Expands Access to Genetic Testing and Risk Assessment Capabilities Available through Volpara’s Breast Health Platform PR Newswire SEATTLE, July 22, 2021 \/PRNewswire\/ —\u00a0Volpara Health,\u00a0a\u00a0global health technology software leader providing an integrated breast care platform for the delivery of personalized\u00a0breast care,\u00a0has\u00a0signed an\u00a0agreement\u00a0with\u00a0Invitae\u00a0Corporation, a leader in medical genetics,\u00a0to bring\u00a0Invitae’s\u00a0genetic testing services to\u00a0Volpara’s\u00a0customers\u00a0in the United States.\u00a0 Volpara’s\u00a0United States\u00a0customers will gain access to\u00a0Invitae’s\u00a0comprehensive\u00a0genetic testing\u00a0services\u00a0within\u00a0Volpara’s\u00a0software workflow. Volpara\u00a0plans to create an\u00a0integrated\u00a0ordering process for\u00a0Invitae\u00a0genetic testing\u00a0services\u00a0within\u00a0its suite of\u00a0products to provide women with additional access to comprehensive genetic testing services through a variety of clinical settings.\u00a0 Customers can utilize\u00a0Volpara’s\u00a0market-leading\u00a0breast cancer risk assessment software\u00a0to\u00a0confidently make informed decisions\u00a0for\u00a0triaging patients to supplemental imaging and\/or genetic testing based on\u00a0their\u00a0personalized\u00a0risk.\u00a0Risk assessment is also required by insurance companies\u00a0in the United States\u00a0to justify reimbursement for … Continue reading \"Volpara Collaborates With Invitae Corporation, Leading Genetics Company\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T12:06:06+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company","datePublished":"2021-07-22T12:06:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/"},"wordCount":564,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/","name":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg","datePublished":"2021-07-22T12:06:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/389465\/Volpara_Solutions_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/volpara-collaborates-with-invitae-corporation-leading-genetics-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Volpara Collaborates With Invitae Corporation, Leading Genetics Company"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}